✦ LIBER ✦

Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancer

✍ Scribed by Takaki Yoshikawa; Akira Tsuburaya; Osamu Kobayashi; Motonori Sairenji; Yohei Miyagi

Publisher: Springer
Year: 2006
Tongue: English
Weight: 182 KB
Volume: 9
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-006-0362-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High levels of tissue inhibitor of metal

High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer

✍ Kevin McCarthy; Teresa Maguire; Gerald McGreal; Enda McDermott; Niall O'Higgins; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 67 KB 👁 2 views

Studies from model systems suggest that matrix metalloproteinases (MMPs) are causally involved in tumor progression while tissue inhibitors of MMPs (TIMPs) prevent this progression. Here, we show that concentrations of TIMP-1 are significantly higher in breast carcinomas than in fibroadenomas. In pr

Tissue inhibitor of matrix metalloprotei

Tissue inhibitor of matrix metalloproteinase-1 in the plasma of patients with gastric carcinoma : A possible marker for serosal invasion and metastasis

✍ Takaki Yoshikawa; Mitsunori Saitoh; Akira Tsuburaya; Osamu Kobayashi; Motonori S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. Expression of the tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in tumor tissue from patients with gastric carcinoma has been reported to be related to disease progression. However, to the authors' knowledge the clinical significance of plasma TIMP-1 concentrations in these

Matrix metalloproteinases 1 and 3, tissu

Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer

✍ Klaus Jung; Lars Nowak; Michael Lein; Friedrich Priem; Dietmar Schnorr; Stefan A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 74 KB 👁 1 views

We analyzed blood plasma concentrations of matrix metalloproteinase-1 and -3 (MMP-1; MMP-3), the tissue inhibitor of metalloproteinase-1 (TIMP-1) and the complex MMP-1/ TIMP-1, and looked for any correlation with prostate cancer stage. These components were measured by ELISA tests specific for these

Plasma Levels of Matrix Metalloproteinas

Plasma Levels of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-1 Correlate With Disease Stage and Survival in Colorectal Cancer Patients

✍ Erwin T. Waas; Thijs Hendriks; Roger M. L. M. Lomme; Theo Wobbes 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 225 KB

Changes in tumor marker levels as a pred

Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma

✍ Bunzo Nakata; Kosei Hirakawa-Y. S. Chung; Kazuya Muguruma; Yoshito Yamashita; Th 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views

## BACKGROUND. Evaluating chemotherapeutic effect in patients with gastric carcinoma sometimes is difficult. The authors investigated whether changes in the serum levels of three tumor markers can be used to predict the clinical outcome after chemotherapy. ## METHODS. Thirty patients with advance

Comparative Enzyme Immunoassay of Matrix

Comparative Enzyme Immunoassay of Matrix Metalloproteinases-2, -7, -9 and Their Tissue Inhibitor-2 in Tumors and Plasma of Patients with Gastric Cancer

✍ E. S. Gerstein; Li Sini; A. B. Ryabov; E. K. Dvorova; A. A. Yurchenko; I. S. Sti 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 251 KB